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ABSTRACT 20 
Contact tracing requires reliable identification of closely related bacterial isolates.   When we noticed 21 
the reporting of artefactual variation between M. tuberculosis isolates during routine next 22 
generation sequencing of Mycobacterium spp, we investigated its basis in 2,018 consecutive M. 23 
tuberculosis isolates.  In the routine process used, clinical samples were decontaminated and 24 
inoculated into broth cultures; from positive broth cultures DNA was extracted, sequenced, reads 25 
mapped, and consensus sequences determined.  We investigated the process of consensus 26 
sequence determination, which selects the most common nucleotide at each position.  Having 27 
determined the high-quality read depth and depth of minor variants across 8,006 M. tuberculosis 28 
genomic regions, we quantified the relationship between the minor variant depth and the amount of 29 
non-Mycobacterial bacterial DNA, which originates from commensal microbes killed during sample 30 
decontamination.  In the presence of non-Mycobacterial bacterial DNA, we found significant 31 
increases in minor variant frequencies of more than 1.5 fold in 242 regions covering 5.1% of the M. 32 
tuberculosis genome.  Included within these were four high variation regions strongly influenced by 33 
the amount of non-Mycobacterial bacterial DNA.  Excluding these four regions from pairwise 34 
distance comparisons reduced biologically implausible variation from 5.2% to 0% in an independent 35 
validation set derived from 226 individuals.  Thus, we have demonstrated an approach identifying 36 
critical genomic regions contributing to clinically relevant artefactual variation in bacterial similarity 37 
searches.  The approach described monitors the outputs of the complex multi-step laboratory and 38 
bioinformatics process, allows periodic process adjustments, and will have application to quality 39 
control of routine bacterial genomics. 40 
 41 
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INTRODUCTION 43 
Identifying closely related bacterial isolates is required for clinical and epidemiological purposes (1-44 
3).   Most published approaches using short-read next generation sequencing (NGS) rely on mapping 45 
to a high-quality reference sequence followed by consensus base calling (1-8).  A known problem 46 
with this approach concerns the existence in many bacterial genomes of ‘hard-to-map’ regions 47 
which are either repeated within the genome, or which contain regions of low sequence complexity.   48 
High-confidence mapping of short reads to such regions is difficult or impossible, and so determining 49 
the consensus sequence of these regions is difficult.  One approach to managing this problem is to 50 
identify these regions bioinformatically prior to mapping by analysis of sequence complexity (9),  or 51 
from repetitiveness within the genome (10).   Base calls within these pre-specified regions are then 52 
ignored (‘masking’) when assessing relatedness of isolate sequences.  A second complementary 53 
approach filters base calls based on read mapping confidence as reported by various mappers (11-54 
14) in the form of Mapping Quality (MAQ) scores.    55 
Mycobacterium tuberculosis is one of the most important pathogens of humans, with about 3 million 56 
cases of TB confirmed by culture globally each year (15).  Recently, laboratory protocols have been 57 
described and deployed by Public Health England (4) in which the species and drug resistance of 58 
Mycobacteria, including M. tuberculosis, are identified by sequencing microbial DNA.  Laboratory 59 
processing of clinical samples suspected of containing Mycobacteria involves decontamination using 60 
chemicals which kill non-Mycobacterial species before the samples are inoculated into broth culture 61 
(16).  Mycobacterial Growth Indicator Tubes (MGIT) and associated tube monitoring equipment are 62 
a commercially available implementation of such a broth culture system.    63 
In the process adopted by Public Health England, sequencing and bioinformatics analysis of DNA 64 
extracted from positive MGIT tubes allows determination of Mycobacterial species and drug 65 
resistance (17).  This laboratory and bioinformatic process also allows the genetic distance between 66 
M. tuberculosis isolates to be estimated, using sequences derived by consensus base calling from 67 
mapped data.  The organism co-evolved with human populations as they migrated, generating 68 
multiple lineages which differ from the ancestral sequence by hundreds or thousands of single 69 
nucleotide polymorphisms (18), as well as small indels, gene deletions and inversions (19).   70 
However, the evolutionary clock rate of the organism is slow at about 0.5 single nucleotide variants 71 
(SNV)/genome/annum (3, 5, 7) and small numbers of single nucleotide variants (SNV) are of clinical 72 
significance:  studies based on retrospective collections of M. tuberculosis, grown on solid media 73 
prior to sequencing, have proposed thresholds of 5 SNVs as compatible with recent transmission (3, 74 
5, 7).  The bioinformatic processes used for relatedness estimation in the deployed pipeline were 75 
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also optimised using samples re-grown from frozen stocks on solid media (Lowenstein-Jensen 76 
slopes) (16).   77 
Quality of complex processes deployed in medical laboratories is assured by adherence to quality 78 
standards, such as those laid out in ISO15189 (20).  These standards require that the processes 79 
followed, and the environments in which they operate, comply with to patterns of work known to 80 
enhance the consistency and interpretability of the laboratory outputs.   For example, in a drug 81 
testing laboratory a set of samples of known composition may be run through the analysers to 82 
confirm that particular commonly found substances which might potentially interfere with the assay 83 
(such as caffeine, paracetamol, and so on) have no impact on detection of the drug of interest.  M. 84 
tuberculosis infection is commonly diagnosed from sputum samples, which contains a wide variety 85 
of organisms other than Mycobacteria (21).   DNA from such organisms may contain sequences 86 
homologous with those present in Mycobacteria, for example in highly conserved core bacterial 87 
genes.  As such, this non-Mycobacterial DNA has the potential to interfere with assays based on 88 
mapping of Mycobacterial reference genome mapping.   89 
Here, we investigate the concept of interfering substances in the context of the detection of closely 90 
related M. tuberculosis isolates.  In particular, we consider whether DNA of non-Mycobacterial origin 91 
might cause interference.  In doing so, we describe a process which we call adaptive masking.  This 92 
defines ‘hard-to-map’ regions existing in the context of the laboratory, sequencing and mapping 93 
processes being used, independently of predictions based on the reference sequence, and of 94 
filtering based on reported mapping quality.  Our work was motivated in part by observations from 95 
analysis of prospective sequencing of M. tuberculosis sequences in England using a previously 96 
described bioinformatics pipeline (17).  It appeared that high SNV distances were being reported 97 
between isolates with a strong epidemiological likelihood of having recently transmitted to each 98 
(e.g. isolates with unusual resistance profiles from individuals who were co-habiting): that is, false 99 
positive variation between isolates was being reported.  We assess the impact of adaptive masking 100 
on addressing this problem, and discuss quality control of relatedness monitoring in the context of 101 
continuous process monitoring in accredited clinical laboratories.   102 
  103 
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METHODS 104 
Isolation of DNA from Mycobacteria and Sequencing 105 
Clinical specimens were decontaminated and inoculated into Mycobacterial Growth Indicator Tubes 106 
(MGIT) tubes (16).  Positive samples were extracted (4).  After DNA extraction, Illumina sequencing 107 
libraries were prepared using either 11 (early in the study) or 15 (later in the study) Mycobacterial 108 
DNA extracts, as previously described (4).  All samples sent from patients for processing for 109 
Mycobacteria between 1/05/2016 and 30/05/2017 to a single reference laboratory were studied; 110 
the catchment of this laboratory is approximately 15 million people, or about one third of England.   111 
Bioinformatic processing   112 
Reads obtained from the MiSeq instrument were first examined for the presence of Mycobacterium 113 
tuberculosis using the Mykrobe tool which detects species-specific k-mers (22).   Only samples 114 
identified as being derived from the M. tuberculosis complex by Mykrobe(22) were considered in 115 
this work.  Additional read classification was performed with Kraken (23), which assigned reads to 116 
bespoke database constructed from (i) all bacterial genomes deposited in the NCBI RefSeq database 117 
as of January 2017 and (ii) Genome Reference Consortium Human genome build 38 (GRCh38) to 118 
allow detection of host DNA as described(24), but with k-mer reduction to 25 gigabases.  We 119 
quantified reads mapped to M. tuberculosis (NCBI taxid: 77643), to non-Mycobacterial bacterial 120 
species, and to humans.  After doing so, human reads were discarded. 121 
Reads were mapped to the H37Rv v2 genome (Genbank NC_000962.2) using Stampy (14), as 122 
described (4).  Samtools (25) was used to assess sequencing and mapping quality: high quality bases 123 
were considered to be those passing the –q30  and–Q30 30 filters (read quality and mapping quality 124 
all >30).   Consensus sequence was called, requiring a minimum-read depth of 5, including at least 125 
one read on each strand. Where an alternative base represented more than 10% of read depth, the 126 
base was recorded as uncertain, as described (26).  127 
The variant call format (VCF) file was parsed with custom python scripts, and the number of high 128 
quality bases (defined using the filters above) at each position determined.  These frequencies were 129 
extracted, stored and indexed using SQLite using a python API constructed to allow extraction of 130 
mixture frequencies in arbitrary positions.  131 
Modelling minor variant frequencies 132 
We determined the most common (major) variant at each position.  All other variants are considered 133 
minor variants.  We define  134 
n    - the total sequencing depth at one base; 135 
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m   - the depth of most common variant at one base; 136 
m’  - the depth of all variants other than most common, n-m (Suppl. Fig. S1).   137 
 138 
We divided up the H37Rv genome based on the annotation in NC_000962.3, identifying 8007 139 
regions R, comprising open reading frames and regions between open reading frames 140 
(Supplementary Data S1).    141 
For each of these regions j=1..8007, if the region has length lj, the total number of minor variant 142 
bases Vj across the i=1..lj bases in the region is given by equation (1) and the total read depth Dj 143 
across the gene by equation (2). 144 
𝑉𝑗 =    ∑ 𝑚𝑙
′𝑙
𝑖=1
  (1) 145 
𝐷𝑗 =    ∑ 𝑛𝑙
𝑙
𝑖=1    (2) 146 
 147 
In order to describe the relationship between non-Mycobacterial DNA quantifications and minor 148 
allele frequency, we stratified the number of reads from each sample identified as being from 149 
bacterial genera other than Mycobacterium (b) into four approximately equally sized strata:   150 
b < 1%,  151 
1% ≤ b < 5%,  152 
5% ≤ b < 20%, 153 
b ≥ 20%.   154 
 155 
We constructed separate Poisson regression models relating minor base counts (V) for each of the 156 
8,007 regions (with log link and offset log(D)) to the non-Mycobacterial bacterial read categories b 157 
(reference category < 1%), excluding any samples with zero high-quality depth in that region.  We 158 
applied Bonferroni correction to model outputs to control for multiple testing (= 0.01/8007 = 159 
1.2x10-6). 160 
Comparing impact of masking on pairwise comparisons 161 
Based on analysis of model output (see Results), regions with higher minor variant counts than 162 
expected were identified.  These regions were excluded from pairwise comparisons performed using 163 
the findNeighbour2 tool (27). 164 
Availability of software and data 165 
The samples studied have been submitted to NCBI with project number PRJNA451404.  Software to 166 
effect the process described, test data, links to the data used, and documentation is freely available 167 
at http://github.com/davidhwyllie/adaptivemasking. 168 
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Impact of mapper 169 
For a random 250 sample subset, we compared the impact of different mappers on minor variant 170 
frequencies across regions using the pipeline above.  We compared mapping with Stampy 171 
1.0.32(14), and Bowtie v 1.2.2 (28) with default parameters, and Bowtie2 v 2.3.4.1 with –very-172 
sensitive and –very-fast preset parameters (29). 173 
Ethical framework 174 
Public health action taken as a result of notification and surveillance is one of the Public Health 175 
England's key roles as stated in the Health and Social Care Act 2012 and subsequent Government 176 
directives which provide the mandate and legislative basis to undertake necessary follow-up. Part of 177 
this follow-up is identification of epidemiological and molecular links between cases.   This work is 178 
part of service development carried out under this framework, and as such explicit ethical approval 179 
is unnecessary. 180 
  181 
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RESULTS 182 
Samples studied 183 
The PHE National Mycobacteriology Reference Laboratory Midlands implemented a laboratory 184 
process in which specimens received are decontaminated, and inoculated in MGIT bottles, DNA 185 
extracts from positive MGIT bottles made, and their contents determined using Illumina short read 186 
sequencing (17).  Using this process, in the 13 months from 1 May 2016 to 30 May 2017, M. 187 
tuberculosis was identified in 2,751 samples, sent from 2,252 patients (Fig. 1).  Using these samples 188 
we derived and validated using an independent validation set (Fig.1) a strategy for investigating and 189 
controlling false positive variation between samples, which we here term adaptive masking (Fig. 2).  190 
The initial stages of adaptive masking involve estimating minor variant frequencies across the 191 
genome from mapped data, and determining whether these are related to the amount of non-192 
Mycobacterial DNA present.    193 
We identified 718 samples from 234 individuals from whom more than one positive sample had 194 
been obtained with 7 days of another.  Of these, in six individuals samples were either reported as 195 
being of different lineages, as defined (30), differed in multiple drug resistances, or differed by >400 196 
high quality SNVs.  These observations we considered likely due to laboratory or sampling mix-ups, 197 
and samples from these patients were excluded.  The other 700 samples were used as an 198 
independent validation set. From remaining samples, we identified the first sample from each of 199 
2,018 individuals which were used to develop the adaptive masking strategy (Fig. 1). 200 
Quantifying extraneous DNA and minor variant frequencies post mapping 201 
We determined the proportion of non-Mycobacterial bacterial DNA in each sample using Kraken 202 
(23), mapped all reads to the H37Rv reference genome irrespective of Kraken results, and filtered 203 
the mapped data using stringent quality filters such that the expected error rate is expected to be 204 
less than 10-3 (see Methods).   We defined 8,007 genomic regions in the reference genome; these 205 
regions comprise all canonical open reading frames and the genomic regions between them 206 
(Supplementary Data S1).   We were unable to assess one 15nt region between two PPE family 207 
members (positions: 3380439 .. 3380453) as no high quality data mapped there in any sample.    208 
In the other 8,006 regions, we observed that both minor variant frequencies and the relationship 209 
between minor variant frequency and the number of reads of non-Mycobacterial origin differed 210 
markedly by gene.  For example, the B55 and esxW genes had respectively very low and very high 211 
minor variant frequencies, independent of non-Mycobacterial DNA quantity.  A small group of 212 
genes, of which the ribosomal component rrs is an example, showed low minor variant frequencies, 213 
except when non-Mycobacterial DNA was present (Figure 3A, B). 214 
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Estimating the impact of extraneous bacterial DNA 215 
We modelled the relationship between minor variant counts and the number of non-Mycobacterial 216 
reads, divided into four approximately equal sized strata (Figure 3B), using Poisson models (Suppl. 217 
Data S2).  Separate models were constructed for each region.  Estimated minor variant frequencies 218 
in samples with <1% non-Mycobacterial bacterial reads had a median of 5x10-4 (Fig. 4A) across the 219 
8006 genomic regions, which is compatible with the expected mapping error rate of <10-3, given the 220 
filters applied.   221 
The distribution of minor variant frequencies when less than 1% non-Mycobacterial bacterial DNA 222 
was present approximated a log-normal distribution with mean log(5x10-4) and standard deviation 223 
equal to the median absolute deviation (Fig. 4A, observed: black line; fitted, red line), but with a tail 224 
to the right.   208 regions (2.6% of the total 8006 regions), including esxW as well as other esx and 225 
PPE family members, had estimated minor variant frequencies > 2.1 x 10-3 when <1% non-226 
Mycobacterial bacterial reads were present (Fig. 4A, Suppl. Data S2).  This cutoff represents four 227 
median absolute deviations above the median; if the data were log-normally distributed, 24 samples 228 
would be expected with minor variant frequencies greater than this, vs. the 208 observed. 229 
Overall, estimated minor variant counts rose as non-Mycobacterial DNA concentration rose, but for 230 
most regions the increase was small (Fig 4B): the median fold change in minor variant counts in the 231 
presence of >20% non-Mycobacterial DNA vs. <1% non-Mycobacterial DNA was 1.097 (i.e. a 9.7% 232 
increase, interquartile range 5.4% to 14.0%).  242 regions (3.0%) had statistically significant increases 233 
(Fig. 4B, 4C) of more than 50%.  Most of these regions had the highest minor variant counts when 234 
>20% non-Mycobacterial DNA was present, although a small number had similar minor variant 235 
counts in the 5-20% range and the >20% range (Suppl. Fig. S2B).    236 
Mutually exclusive regions with increased minor variant frequency 237 
Comparing regions with increased minor variant rates with low (<1%) non-Mycobacterial bacterial 238 
DNA with those with increased minor variant rates with high (>20%) non-Mycobacterial bacterial 239 
DNA shows these regions to be mutually exclusive (Fig. 5).  The former include PPE and esx family 240 
members, while the latter include ribosomal components (rrl, rrs, rplB, and rps genes) as well as 241 
other highly conserved bacterial genes (tRNA genes, fusA1, infA, dnaK, and others) (Fig. 5, Suppl. 242 
Data S2).   243 
Examining Kraken read assignments in reads mapped to these highly conserved genes indicated that 244 
many reads mapping to these highly conserved regions cannot be unambiguously assigned to the M. 245 
tuberculosis taxon (Supp. Fig. 3) even when non-Mycobacterial bacterial DNA is not present, or is 246 
present in small amounts.   For example,  in the 422 samples for which <1% of total bacterial DNA is 247 
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non-Mycobacterial, only a small proportion (27.3%) of reads mapping with high quality to rrs are 248 
assigned to the Mycobacterium genus by Kraken.  However, since very little if any non-Mycobacterial 249 
bacterial DNA is present, these reads are almost certainly derived from M. tuberculosis rrs.   By 250 
contrast, the corresponding figure for a gene with little homology with non-Mycobacterial genomes 251 
(B55) is 97.4%.  The corollary is that if one routinely removes reads which are not assigned by Kraken 252 
to the genus of interest (in this case Mycobacterium), one will remove a very high proportion of the 253 
reads corresponding to critical loci (including drug targets, such as rrs) even when no non-254 
Mycobacterial bacterial DNA, as occurs if one was sequencing pure cultures.   255 
Adaptive masking reduces the reporting of biologically implausible inter-individual variation 256 
A published strategy for excluding regions of high mapping variation within the M. tuberculosis 257 
genome strategy masks (i.e. excludes from relatedness computations) 277,709 nt (6.3%) of the 258 
genome (4).  Excluding regions with high estimated minor variant counts with <1% non-259 
Mycobacterial DNA (zone A in Fig. 5B) adds an additional 1.1%.  Excluding regions with increased 260 
estimated minor variant counts only in the presence of >20% non-Mycobacterial bacterial DNA 261 
(zones B-D) masks between 0.2% and 5.1% extra (Fig 5B,C).  The masking of regions identified by 262 
‘adapting’ to variation generated during the process forms the final part of the adaptive masking 263 
process. 264 
In a validation set comprising isolates taken with 7 days of each other from 234 individuals, using the 265 
published strategy, 18/346 (5.2%) of pairs studied had ≥ 5 SNV variation, of which 10/346 were ≥ 266 
20SNV.  On exclusion of region D, which comprises the four genes most influenced by non-267 
Mycobacterial DNA, all encoding ribosome associated products (the genes rrl and rrs, together with 268 
the tRNA metU, and the highly conserved bacterial gene tuf), 0/346 pairs differed by >= 5 SNP (p < 269 
10-4 compared with the published method, Wilcoxon test on pairs).   These genes were the only 270 
genes with minor variant frequencies significantly affected by non-Mycobacterial DNA at the 1 to 5% 271 
level (Figure 4B top panel; Supplementary Data Supplementary S2).  Additional exclusion of genes in 272 
regions B and C, mapping to which is less influenced by non-Mycobacterial DNA, had a limited 273 
impact (Figure 6).   274 
Impact of mapper 275 
In the above work, we use the Stampy mapper(14) which forms part of the deployed TB 276 
bioinformatics pipeline(17).  To determine whether the choice of mapper was important, we 277 
compared the results of mapping a 250 sample test set to the H37Rv reference genome using four 278 
different software/parameter settings.  We identified regions with any significantly increased 279 
mixture frequencies when >20% non-Mycobacterial bacterial DNA was present relative to when <1% 280 
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was present using a p-value of 0.05, adjusted by Bonferroni’s method to 7.6 x 10-6.  The numbers of 281 
such regions detected with Stampy, bowtie, and bowtie2 with both stringent and more relaxed 282 
matching criteria were 2544, 25, 70, and 72 respectively (Supplementary Data S3).  Increased in 283 
minor variants frequencies in rrl were detected by all techniques; estimated fold increases in minor 284 
variant frequencies associated with >20% non-Mycobacterial bacterial DNA were 37, 1.4, 1.5, and 285 
1.5 respectively.  Thus, although the mismapping observed identified occurs in all cases examined, it 286 
is much more prominent with Stampy than with the bowtie series of mappers. 287 
 288 
 289 
 290 
  291 
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DISCUSSION  292 
Here, we describe an approach which we term adaptive masking.  This involves monitoring the 293 
minor variant frequency across a bacterial genome to which sequencing reads have been mapped; 294 
as such, it measures an end product of next generation sequencing processes, taking into account 295 
the natural sequence variation in the samples studied, as well as the impact of DNA extraction and 296 
library construction technologies, and the performance of the mapping and filtering software used.   297 
Using this approach, we defined a set of ‘hard to map’ genetic regions (zone A, Fig. 5) with increased 298 
minor variant frequencies irrespective of the amount of non-Mycobacterial bacterial DNA.   299 
Exclusion of these regions could be considered when assessing consensus M. tuberculosis sequences.   300 
We also demonstrated a significant positive association between amounts of non-Mycobacterial 301 
bacterial DNA and minor variant frequencies in a subset of the mapped genome:  significant 302 
increases of more than 1.5 fold were observed in 242/8006 regions examined, which together cover 303 
about 5% of the M. tuberculosis genome.  Although the emphasis of this work is on relatedness 304 
between isolates, it is notable that included within the 242 regions are a series of genes encoding 305 
ribosomal components (rrs,  rrl, rpoB, rpsL, rpsA) which correspond to major antituberculous drug 306 
resistance genes(31).  Therefore, studies investigating resistance or heteroresistance using these loci 307 
should report estimates of the impact of the presence of non-Mycobacterial bacterial DNA on 308 
heteroresistance estimates.  Such interference may be particularly marked when direct-from-sample 309 
short read sequencing is used(32), given the increased ratio of non-Mycobacterial : Mycobacterial 310 
DNA in the absence of selective Mycobacterial amplification using culture.   311 
Among these 242 regions we identified four ‘high variation’ regions in which minor variant 312 
frequencies are very strongly influenced by non-Mycobacterial bacterial DNA quantities, with fold-313 
increases in minor variant frequencies of >5 in the presence of >20% non-Mycobacterial bacterial 314 
DNA.  Importantly, if non-Mycobacterial bacterial DNA concentrations are low (<1% of bacterial DNA 315 
present), as occurred in retrospective studies when Mycobacteria were subcultured on Lowenstein-316 
Jensen slopes prior to sequencing, increased variation is not observed in these regions.  The 317 
exclusion of the four ‘high variation’ regions from base calling by a clinically deployed M. 318 
tuberculosis pipeline markedly reduced reported variation between samples derived from the same 319 
patient in a short time period.  In particular, prior to exclusion of the four high variation regions, in a 320 
test set derived from 234 individuals, 5.2% of intra-patient pairs examined differed by 5 SNV or 321 
more, with the majority of SNV differences observed in these pairs being >20.  Multiple studies 322 
indicate this is biologically implausible (3, 5, 7), and after exclusion of the four ‘high variation’ 323 
regions comprising only 0.2% of the genome, no pairs had variation of 5 SNV or more.  This suggests 324 
 o
n
 June 29, 2018 by YO
RK TEACHING
 HO
SPITAL
http://jcm.asm.org/
D
ow
nloaded from
 
  
that using standard ‘masking’ and DNA extraction from liquid media false positive variation is 325 
reported in a small number of sites in a non-Mycobacterial bacterial DNA dependent manner.  Put 326 
alternatively, non-Mycobacterial bacterial DNA acts as an interfering substance (20) for relatedness 327 
measurements.   328 
A potential limitation of this work is that this approach studies pre-specified regions of the genome, 329 
specifically coding regions and intergenic regions.  This approach was chosen to avoid the challenges 330 
of analysing the 4.4 x 106 bases of the M. tuberculosis genome individually, with concomitant loss of 331 
statistical power. Therefore, as described the method may neither detect, nor allow selective 332 
masking of, small regions with high minor variant frequencies within genes.  A second limitation is 333 
that we did not use of metagenomics classifiers, such as Kraken, to identify non-Mycobacterial 334 
‘interfering’ DNA and eliminate it prior to mapping to the M. tuberculosis genome.  We did not do 335 
this because we observed that for the highly conserved rrs genes, metagenomic classifiers cannot 336 
confidently assign reads to a genus level, likely because there is insufficient sequence variation 337 
within short read sequencing of rrs to allow this.  Therefore, until longer read sequencing become 338 
available sequencing less conserved flanking genomic regions, a strategy of read  removal based on 339 
metagenomics classification will eliminate a high proportion of bona fide M. tuberculosis derived 340 
reads in conserved genes, even in samples without any non-Mycobacterial bacterial DNA.  Despite 341 
these limitations, the strategy chosen appears to be of use clinically, based on the reduction in likely 342 
false positive variation between serial samples from individuals. 343 
The routine clinical of use of next generation sequencing is rapidly increasing (1, 4, 22).  However, 344 
the reporting of microbial identity, resistotyping, and relatedness information requires complex, 345 
multistep processes whose outputs are dependent on specimen decolonisation, selective culture, 346 
DNA extraction, library construction, DNA sequencing, and bioinformatic analysis (4).   Reagent 347 
batches, software versions, and equipment involved in the process are all subject to change over 348 
time.    The adaptive masking approach we describe here represents a route to the quantitative 349 
monitoring the performance of the output of this pathway, identifying whether changes in process 350 
which may appear innocuous alter mapping and basecalling across the  genome.   We do not 351 
propose that the output from the adaptive masking process as demonstrated here with data 352 
generated by Public Health England and processed by particular bioinformatics tools should be used 353 
to generate a list of problematic genomic regions which can be universally applied.  Rather, we 354 
envisage that the adaptive masking process will be performed as part of the acceptance of process 355 
change, and periodically as part of quality monitoring, under the exact conditions used in the clinical 356 
laboratory issuing NGS based results.   A list of problematic positions to be ignored during 357 
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relatedness calculations can then be fed into systems doing such calculations, such as 358 
findNeighbour2 (27), which would apply such masking across all samples. 359 
Generalizable to other organisms and mapping pipelines, the adaptive masking approach we 360 
described here will have application in monitoring the performance of such processes quantitatively, 361 
in interpreting estimates of possible heteroresistance, and in preventing the calling of false positive 362 
variation in the context of clinically deployed genomics.   363 
  364 
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FIGURE LEGENDS 489 
Figure 1 Samples used, derivation and validation sets 490 
A flow chart describing the samples used, and the selection of derivation and validation sets. 491 
Figure 2 Bioinformatic Processes 492 
A flow diagram illustrating the standard bioinformatics pipeline used, as well as the adaptive 493 
masking process used to generate masks.  Gray circles denote links to a description of the process at 494 
https://github.com/davidhwyllie/adaptivemasking.  FindNeighbour2 is an open-source server-based 495 
system for monitoring single nucleotide variation(27).   496 
Figure 3 Minor variant frequency and non-Mycobacterial bacterial DNA quantities 497 
The observed minor variant frequency for three regions of the M. tuberculosis genome (genes B55, 498 
eswX, and rrs) vs. the proportion of reads of non-Mycobacterial bacterial origin (as determined by 499 
Kraken) is shown for samples in the derivation set (n=2018).  Panel (A) shows a dot plot, whereas in 500 
panel (B) the proportion of reads of non-Mycobacterial bacterial origin is stratified into strata with 501 
1%, 5% and 20% boundaries.  Numbers above each stratum refer to the number of samples with 502 
non-zero read depth in that region.   503 
Figure 4 Modelling minor variant frequencies 504 
For 8,006 genomic regions of the H37Rv reference genome, Poisson models were used to estimate 505 
the mean minor variant frequency.  The estimated minor variant frequency when less than 1% non-506 
Mycobacterial bacterial DNA is present (n=208, 2.6% regions) is shown in (A).  The red line is a log 507 
normal distribution with = log(minor variant frequency with <1% non-Mycobacterial DNA) and  = 508 
median absolute deviation(log(minor variant frequency with <1% non-Mycobacterial DNA)).   In (B) 509 
the rate ratio estimates (i.e. the fold change associated with increases in non-Mycobacterial 510 
bacterial DNA quantifications) for each gene are shown.  (C) shows the significance of a test 511 
comparing the log(rate ratio estimates) with zero, in the form of a Volcano plot.  The dotted lines in 512 
(B) and (C) correspond to a 50% increase in rate ratio. 513 
 514 
Figure 5 A distinct subset of genes are impacted by quantity of non-Mycobacterial DNA  515 
Legend: (A) Fold change in minor variant frequency with > 20% non-Mycobacterial bacterial DNA 516 
present vs. <1% non-Mycobacterial bacterial DNA.  Quadrant boundary markers correspond to 517 
(horizontal line) a 50% increase over <1% non-Mycobacterial bacterial DNA and (vertical line) a 518 
minor variant frequency of 2.1x10-3.  (B) Genes with elevated minor variant frequencies when non-519 
Mycobacterial bacterial DNA is low (<1%) or high (>20%) fall into mutually exclusive sets.  (C) the 520 
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number of bases represented by the deployed masking, vs. the deployed masking plus the genes in 521 
zones A, A+D, A+D+C, and A+D+C+B. 522 
Figure 6 Impact of masking strategies on reported distances between closely related samples 523 
SNV distances between pairs of M. tuberculosis genomes isolates from samples taken from the same 524 
individual within 7 days of each other were compared using different masking strategies.   The top 525 
panel describes the published, deployed method of masking.  In the panels below, genes in the 526 
zones shown in Figure 5B are additionally masked (i.e. ignored from pairwise comparisons).  527 
 528 
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